Vironeto 300 mg Tablet
PDF Leaflet Revision Date: 12 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection and chronic hepatitis B.
Dosage (summary)
300 mg once daily orally, with or without food.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Didanosine
- Adefovir dipivoxil
- Atazanavir
- Lopinavir/ritonavir
Contraindications
- Hypersensitivity to tenofovir
- Pregnancy
- Lactation
Common side effects
- Nausea
- Diarrhea
- Dizziness
- Fatigue
Counselling Points
- Monitor renal function
- Avoid breastfeeding
- Report symptoms of lactic acidosis
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Renal impairment
Important Disclaimer
The Vironeto 300 mg Tablet professional information leaflet below is the property of Strides Pharma (Sa) Pty Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
